| 0 (0%) | 01-14 09:37 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term | |
|||
| Targets | 6-month : | 4.43 | 1-year : | 5.18 |
| Resists | First : | 3.79 | Second : | 4.43 |
| Pivot price | 3.34 |
|||
| Supports | First : | 3.02 | Second : | 2.53 |
| MAs | MA(5) : | 3.54 |
MA(20) : | 3.28 |
| MA(100) : | 2.96 |
MA(250) : | 2.44 |
|
| MACD | MACD : | 0.1 |
Signal : | 0.1 |
| %K %D | K(14,3) : | 76.8 |
D(3) : | 72.9 |
| RSI | RSI(14): 62.9 |
|||
| 52-week | High : | 4 | Low : | 1.42 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ ACIU ] has closed below upper band by 4.5%. Bollinger Bands are 6.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 3.74 - 3.76 | 3.76 - 3.77 |
| Low: | 3.38 - 3.4 | 3.4 - 3.41 |
| Close: | 3.67 - 3.7 | 3.7 - 3.72 |
Thu, 08 Jan 2026
Insider Trends: Will ACIU stock continue dividend increases - Dividend Hike & Free Long-Term Investment Growth Plans - Улправда
Thu, 08 Jan 2026
Retail investors are AC Immune SA's (NASDAQ:ACIU) biggest owners and were rewarded after market cap rose by US$53m last week - Yahoo Finance
Wed, 07 Jan 2026
H.C. Wainwright Maintains AC Immune(ACIU.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛
Thu, 11 Dec 2025
AC Immune SA (ACIU) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Thu, 11 Dec 2025
Why Is AC Immune Stock Up Over 23% Today? - Stocktwits
Thu, 11 Dec 2025
AC Immune (NASDAQ: ACIU) Phase 2 data show stabilized markers in Parkinson’s - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 101 (M) |
| Held by Insiders | 4.006e+007 (%) |
| Held by Institutions | 38 (%) |
| Shares Short | 1,620 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -7.165e+007 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -1 % |
| Return on Assets (ttm) | 671.8 % |
| Return on Equity (ttm) | -22 % |
| Qtrly Rev. Growth | 4.37e+006 % |
| Gross Profit (p.s.) | -60.19 |
| Sales Per Share | -46.65 |
| EBITDA (p.s.) | -3.57687e+007 |
| Qtrly Earnings Growth | -1 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -47 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.08 |
| Price to Cash Flow | 7.58 |
| Dividend | 0 |
| Forward Dividend | 3.59e+006 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|